To determine the efficacy and safety of zoledronic acid therapy in the prevention and treatment of postmenopausal osteoporosis compared to placebo or active comparator (other bisphosphonates).
This is a protocol.
Intravenous zoledronate for postmenopausal osteoporosis
You may also be interested in:
- Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplasty
- Etidronate for preventing fractures caused by osteoporosis in postmenopausal women
- Selective estrogen receptor modulators for preventing and treating postmenopausal osteoporosis
- Pharmacological interventions for preventing bone density loss in critically ill people
- Statins for osteoporosis in postmenopausal women
Health topics: